Title for MeetingAbstracts
Alphabetical listing of titles
Metabolic and structural effects of the interaction of HIV with PBL and lymphoblastoid cells can be monitored with 1H NMR.
Metabolic and thermoregulatory responses to head down suspension of hypophysectomized rats.
Metabolic changes after antiretroviral interruption.
Metabolic changes in HIV-infected patients treated with protease inhibitors.
Metabolic Changes in Patients Switching from a Protease Inhibitor-Containing Regimen to Abacavir, Efavirenz,) or Nevirapine: 24-Month Results of a Randomized Study.
Metabolic cofactors associated with progression to KS or PCP as the initial diagnosis of AIDS.
Metabolic complications and lipodystrophy in HIV infected children receiving highly active antiretroviral therapy (HAART).
Metabolic Complications of HIV Disease.
Metabolic disturbances in AIDS: the role of circulating interferon alpha (IFNa) and tumor necrosis factor (TNF) in the hypertriglyceridemia of AIDS.
Metabolic Effects And Lipodystrophy Body-Shape Changes after Replacing Stavudine by Abacavir.
Metabolic effects of antiretroviral therapy.
Metabolic effects of intermittent Antiretroviral Therapy with and without IL-2 (ACTG A5102).
Metabolic Effects of Lopinavir/Ritonavir (Kaletra) in Healthy HIV-seronegative Men.
Metabolic parameters during long-term supervised treatment interruption (LT-STI).
Metabolic parameters in HIV-positive adults treated with Fortovase (saquinavir SGC; FTV) TID and BID combination therapy regimens.
Metabolic Parameters in HIV-Positive Adults Treated with Fortovase(tm) (saquinavir SGC; FTV) TID and BID Combination Therapy Regimens.
Metabolic peculiarities of T-lymphocytes in HIV-infected patients.
Metabolic side effects of antiretroviral therapy in the swiss cohort study.
Metabolic Specificity Profiling of Fluoroquinolones, Non-Fluorinated Quinolones, and Other DNA Topoisomerase Inhibitors Against Intact Cells of Staphylococcus aureus.
Metabolic Specificity Profiling of Various Biocide Classes against Staphylococcus aureus.
Metabolic syndrome in an HIV+ drug using population in Miami.
Metabolism in vitro and in vivo.
Metabolism Interactions to Improve Systemic Exposure.
Metabolism of rifabutin and drug interactions with the macrolide antibiotics in human liver microsomes.
Metabolism of rifabutin in the rat.
Metabolism of T-lymphocytes in HIV-infected patients.
Metabolism, ultrastructure and growth of soybean seedlings in microgravity: results from the BRIC-01 and BRIC-03 experiments.
Metamorphosis of an oxymoron: case study of a Ryan White CARE Act network.
Metapneumovirus Infections in Infants and Children.
Methadone and harm reduction: the changing meaning of treatment effectiveness.